Research Article
Alteration of Angiopoietin-Like Protein 4 Levels in Serum or Urine Correlate with Different Biochemical Markers in Hyperlipidemia-Related Proteinuria
Table 9
Expression of ANGPTL4 in serum and urine in patients with proteinuria (HL-Pro/NHL-Pro group) among the different GFR classification groups.
| | Group () | GFR () (ml/min·1.73 m2) | Serum ANGPTL4 (ng/ml) | Urine ANGPTL4/Cr (μg/g) |
| | HL-Pro group () | Phase 1 (44) | 21.94 (18.60, 48.85) | 50.02 (43.97, 75.11) | | Phase 2 (10) | 19.56 (18.26, 25.19) | 55.53 (45.25, 107.44) | | Phase 3, 4 (14) | 79.70 (21.43, 95.01) | 52.39 (49.46, 90.87) | | 11.842 | 5.542 | | 0.008 | 0.136 |
| | NHL-Pro group () | Phase 1 (24) | | 33.43 (25.96, 66.33) | | Phase 2 (8) | | 50.43 (44.19, 61.20) | | Phase 3 (10) | | 105.78 (97.34, 112.14) | | Phase 4, 5 (4) | | 64.02 (40.07, 87.97) | | 0.362 | 16.311 | | 0.834 | 0.001 |
|
|
